Metastatic Microsatellite Stable Colorectal Carcinoma
13 clinical trials · Condition
◉ Watch Metastatic Microsatellite Stable Colorectal Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer (NCT05130060) | Mayo Clinic | 2022-01-10 |
| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |
| Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer (NCT03576963) | University of Southern California | 2020-01-30 |
| Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NCT03983993) | Emory University | 2019-10-15 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650) | M.D. Anderson Cancer Center | 2019-06-14 |
| Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer (NCT03800602) | Emory University | 2019-01-15 |
Track Metastatic Microsatellite Stable Colorectal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.